764
S. Majumder, P. J. Bhuyan / Tetrahedron Letters 53 (2012) 762–764
under reduced pressure and the residue was purified by preparative TLC using
ethyl acetate/hexane (4:6) as eluent to give 5a and 6a.
fused heterocyclic compounds of biological importance. Further
study of the reaction is in progress.
Compound 5a: Yield: 0.411 g (75%), mp 157–158 °C. 1H NMR (300 MHz,
CDCl3): d 1.35 (s, 6H), 2.90 (s, 3H), 3.15–3.29 (m, 1H), 3.86 (d, J = 3.2 Hz, 1H),
4.31–4.36 (m, 2H), 7.20–7.90 (m, 4H), 8.10 (s, 1H). 13C NMR (75 MHz, CDCl3): d
27.43 (2C), 29.56, 34.21, 66.51, 69.12, 106.49, 113.74, 119.82, 121.60, 126.02,
133.45 142.72, 148.15, 151.94. m/z [ M+H]+ 275.5. CHN analysis (calcd) C,
65.69; H, 6.56; N, 10.22; C15H18N2OS (found) C, 65.32; H, 6.48; N, 10.52.
Compound 6a: Yield: 0.065 g (12%), mp 149–150 °C. 1H NMR (300 MHz,
CDCl3): d 1.32 (s, 6H), 2.85 (s, 3H), 3.22–3.31 (m, 1H), 3.90 (d, J = 9.4 Hz, 1H),
3.92–3.99 (m, 2H), 7.2–8.0 (m, 4H), 8.15 (s, 1H). 13C NMR (75 MHz, CDCl3): d
26.74 (2C), 28.98, 33.45, 65.48, 69.03, 105.66, 111.80, 118.32, 120.73, 124.40,
131.54, 139.76, 147.90, 151.04. m/z [M+H]+ 275.5. CHN analysis (calcd) C,
65.69; H, 6.56; N, 10.22; C15H18N2OS (found) C, 65.20; H, 6.38; N, 10.58.
Compound 5b. Yield: 0.499 g (73%), mp 135–136 °C. 1H NMR (300 MHz,
CDCl3): d 1.13–1.30 (m, 4H), 1.33 (s, 6H), 1.56–1.97 (m, 6H), 2.59–2.65 (m, 1H),
3.12–3.25 (m, 1H), 3.88 (d, J = 4.1 Hz, 1H), 4.25–4.38 (m, 2H), 7.17–7.93 (m,
4H), 8.10 (s, br, 1H). 13C NMR (75 MHz, CDCl3): d 24.52 (2C), 25.84 (2C), 27.56,
27.97 (2C), 29.82, 66.51, 67.89 70.45, 107.80, 112.52, 120.68, 122.84, 127.06,
134.94, 143.60, 149.18, 153.02. m/z [M+H]+ 343.6. CHN analysis (calcd) C,
70.17; H, 7.60; N, 8.18; C20H26N2OS (found) C, 69.98; H, 7.64; N, 8.02.
Compound 6b: Yield: 0.054 g (8%), mp 127–128 °C. 1H NMR (300 MHz, CDCl3):
d): d 1.11–1.32 (m, 4H), 1.35 (s, 6H), 1.53–1.95 (m, 6H), 2.56–2.63 (m, 1H),
3.14–3.26 (m, 1H), 3.87 (d, J = 9.6 Hz, 1H), 4.22–4.33 (m, 2H), 7.16–7.91 (m,
4H), 8.18 (s, br,1H). 13C NMR (75 MHz, CDCl3): d 24.34 (2C), 26.03 (2C), 28.53,
28.92 (2C), 30.64, 65.72, 68.35 70.58, 107.51, 111.80, 121.40, 122.21, 126.85,
133.43, 143.75, 147.91, 152.52. m/z [M+H]+ 343.6. CHN analysis (calcd) C,
70.17; H, 7.60; N, 8.18; C20H26N2OS (found) C, 70.12; H, 7.01; N, 8.08.
Compound 5c. Yield: 0.385 g (67%), mp 187–189 °C. 1H NMR (300 MHz, CDCl3):
d 1.34 (s, 6H), 2.98 (s, 3H), 3.10–3.29 (m, 1H), 3.63 (s, 3H), 3.89 (d, J = 4.6 Hz,
1H), 4.29–4.41 (m, 2H), 7.22–7.78 (m, 4H), 8.23 (s, br, 1H). 13C NMR (75 MHz,
CDCl3): d 25.57 (2C), 29.31, 36.76, 39.60, 66.29, 70.12, 108.74, 113.93, 118.58,
Acknowledgments
The authors thank DST, New Delhi for financial support. Mr. S.
Majumder thanks CSIR for a research fellowship.
References and notes
1. (a) Faulkner, D. J. Nat. Prod. Rep. 1999, 16, 155; (b) Lounasmaa, M.; Tolvanen, A.
Nat. Prod. Rep. 2000, 17, 175.
2. (a) Takada, S.; Ishizuka, N.; Sasatani, T.; Makisumi, Y.; Jyoyama, H.;
Hatakeyama, H.; Asanuma, F.; Hirose, K. Chem. Pharm. Bull. 1984, 32, 877; (b)
Takada, S.; Makisumi, Y. Chem. Pharm. Bull. 1984, 32, 872.
3. (a) Mullen, G. B.; Decory, T. R.; Mitchell, J. T.; Allen, S. D.; Kinssolving, C. R.;
Georgiev, V. S. J. Med. Chem. 1988, 31, 2008; (b) Green, M. J.; Tiberi, R. L.; Friary,
R.; Lutsky, B. N.; Berkenkoph, J.; Fernandez, X.; Monahan, M. J. Med. Chem. 1982,
25, 1492; (c) Raunak, R.; Kumar, V.; Mukherjee, S.; Poonam, A. K.; Prasad, K.;
Olsen, C. E.; Schaffer, S. J. C.; Sharma, S. K.; Watterson, A. C.; Errington, W.;
Parmar, V. S. Tetrahedron 2005, 61, 5687; (d) Wu, Y.; Dai, G. F.; Yang, J. H.;
Zhang, Y. X.; Zhu, Y.; Tao, J. C. Bioorg. Med. Chem. Lett. 2009, 19, 1818; (e)
Rescifina, A.; Chiacchio, M. A.; Corsaro, A.; De Clercq, E.; Iannazzo, D.; Mastino,
A.; Piperno, A.; Romeo, G.; Romeo, R.; Valveri, V. J. Med. Chem. 2006, 49, 709.
4. (a) Pandey, G.; Banerjee, P.; Gadre, S. R. Chem. Rev 2006, 106, 4484; (b) Gothelf,
K. V.; Jørgensen, K. A. Chem. Rev. 1998, 98, 863; (c) Mita, T.; Ohtsuki, N.; Ikeno,
T.; Yamada, T. Org. Lett. 2002, 4, 2457; (d) Stephens, B. E.; Liu, F. J. Org. Chem.
2009, 74, 254; (e) Legeay, J. C.; Langlois, N. J. Org. Chem. 2007, 72, 10108; (f)
Oppolzer, W.; Weber, H. P. Tetrahedron Lett. 1970, 11, 1121; (g) Busque, F.; de
March, P.; Figueredo, M.; Font, J.; Monsalvatje, M.; Virgili, A.; Alvarez-Larena,
A.; Piniella, J. F. J. Org. Chem. 1996, 61, 8578; (h) Coldham, I.; Hufton, R. Chem.
Rev. 2005, 105, 2765.
121.65, 126.73, 136.45, 144.30, 148.45, 152.86. m/z
analysis (calcd) C, 66.66; H, 6.94; N, 9.72; C16H20N2OS (found) C, 66.54; H, 6.48;
N, 9.82.
[
M+H]+ 289.7. CHN
5. (a) Ingal, A. H. In Comprehensive Heterocyclic Chemistry; Boulton, A. S., McKillop,
A., Eds.; Pergamon press: Oxford, 1984; Vol. 3, p 773; (b) Talley, J. J. J. Org. Chem.
1985, 50, 1695; (c) Boger, D. L.; Weinreb, S. M. In Hetero Diels–AlderMethodology
in Organic Synthesis; Academic Press: New York, 1987; p 225; (d) Inamoto, N.
Heteroatom Chem. 2001, 12, 183; (e) Majumdar, K. C.; Jana, M. Synth. Commun.
2007, 37, 1375; (f) Majumdar, K. C.; Basu, P. K.; Mukhopadhyay, P. P.; Sarkar, S.;
Ghosh, S. K.; Biswas, P. Tetrahedron 2003, 59, 2151; (g) Majumdar, K. C.;
Mukhopadhyay, P. P. Synthesis 2003, 97.
6. (a) Jayashankaran, J.; Manian, R. D. R. S.; Raghunathan, R. Tetrahedron Lett.
2006, 47, 2265; (b) Matiychuk, V. S.; Lesyk, R. B.; Obushak, M. D.; Gzella, A.;
Atamanyuk, D. V.; Ostapiuk, Y. V.; Kryshchyshyn, A. P. Tetrahedron Lett. 2008,
49, 4648; (c) Majumdar, K. C.; Muhuri, S. Synthesis 2006, 2725; (d) Majumdar,
K. C.; Kundu, U. K.; Ghosh, S. K. Org. Lett. 2002, 4, 2629; (e) Majumdar, K. C.;
Taher, A.; Ray, K. Tetrahedron Lett. 2009, 50, 3889.
7. (a) Al-Nakib, T.; Bezjak, V.; Rashid, S.; Fullam, B.; Meegan, M. J. Eur. J. Med.
Chem. 1991, 26, 221; (b) Al-Nakib, T.; Bezjak, V.; Meegan, M. J.; Chandy, R. Eur. J.
Med. Chem. 1990, 25, 455; (c) Van Vliet, L. A.; Rodenhuis, N.; Dijkstra, D.;
Wikstroem, H.; Pugsley, T. A.; Serpa, K. A.; Meltzer, L. T.; Heffner, T. G.; Wise, L.
D.; Lajiness, M. E.; Huff, R. M.; Svensson, K.; Sundell, S.; Lundmark, M. J. Med.
Chem. 2000, 43, 2871.
8. (a) Katritzky, A. R.; Button, M. A. C. J. Org. Chem. 2001, 66, 5595; (b) Ram, V. J.;
Srivastava, P.; Saxena, A. S. J. Org. Chem. 2001, 66, 5333; (c) Hori, M.; Kataoka,
T.; Shimizu, H.; Imai, E.; Iwata, N.; Kawamura, N.; Kurono, M.; Nakano, K.; Kido,
M. Chem. Pharm. Bull. 1989, 37, 1282.
Compound 6c: Yield: 0.040 g (7%), mp 183–184 °C. 1 H NMR (300 MHz, CDCl3):
d 1.35 (s, 6H), 2.89 (s, 3H), 3.15–3.29 (m, 1H), 3.64 (s, 3H), 3.89 (d, J = 10.4 Hz,
1H), 4.18–4.35 (m, 2H), 7.19–7.88 (m, 4H), 8.29 (s, br,1H). 13C NMR (75 MHz,
CDCl3): d 25.53 (2C), 29.32, 35.86, 38.62, 67.54, 69.62, 107.98, 112.79 119.72,
121.50, 126.45, 135.57, 145.12, 146.58, 152.67. m/z [M+H]+ 289.7. CHN
analysis (calcd) C, 66.66; H, 6.94; N, 9.72; C16H20N2OS (found) C, 66.49; H,
6.61; N, 9.88. Compound 5d: Yield: 0.484 g (68%), mp 174–175 °C. 1H NMR
(300 MHz, CDCl3): d 1.12–1.33 (m, 4H), 1.34 (s, 6H), 1.57–1.98 (m, 6H), 2.53–
2.68 (m, 1H), 3.13–3.26 (m, 1H), 3.64 (s, 3H), 3.88 (d, J = 4.8 Hz, 1H), 4.23–4.38
(m, 2H), 7.21–7.96 (m, 4H), 8.26 (s, br, 1H). 13C NMR (75 MHz, CDCl3): d 24.12
(2C), 25.46 (2C), 26.86, 27.24 (2C), 29.74, 35.89, 65.72, 67.71, 70.08, 107.48,
113.86, 119.48, 121.35, 127.96, 135.08, 145.59, 148.98, 154.14. m/z [M+H]+
357.8. CHN analysis (calcd) C, 70.78; H, 7.86; N, 7.86; C21H28N2OS (found) C,
70.65; H, 7.57; N, 8.02. Compound 6d: Yield: 0.056 g (8%), mp 171–172 °C. 1H
NMR (300 MHz, CDCl3): d 1.18–1.36 (m, 4H), 1.33 (s, 6H), 1.50–1.98 (m, 6H),
2.48–2.68 (m, 1H), 3.13–3.28 (m, 1H), 3.64 (s, 3H), 3.87 (d, J = 10.9 Hz, 1H),
4.28–4.39 (m, 2H), 7.19–7.99 (m, 4H), 8.22 (s, br, 1H). 13C NMR (75 MHz,
CDCl3): d 24.14 (2C), 25.23 (2C), 26.41, 27.02 (2C), 30.01, 36.08, 65.68, 68.59,
70.12, 108.24, 112.89, 120.76, 121.29, 126.52, 134.71, 144.79, 147.99, 153.58.
m/z [M+H]+ 357.8 CHN analysis (calcd) C, 70.78; H, 7.86; N, 7.86; C21H28N2OS
(found) C, 70.62; H, 7.61; N, 7.98.
17. Compound 4a (2 mmol, 0.488 g) in 6 ml of EtOH was reacted with an aqueous
solution of hydroxylamine prepared by adding NaOH (0.175 g in 4 ml H2O) to a
solution of NH2OH/HCl (0.166 g, 2 mmol in 3 ml water), with stirring at room
temperature. After 10 min, the solution was clear. The reaction mixture was
allowed to stir at room temperature for 1 h after which the EtOH was
evaporated and the compound was separated by extraction with
dichloromethane. The organic extract was dried over anhydrous sodium
sulphate and then evaporated under reduced pressure to obtain 7a.
Recrystallised from chloroform. Yield: 72%, mp 147–148 °C. 1H NMR
(300 MHz, CDCl3): d 1.45 (s, 6H), 3.76 (d, J = 4.8 Hz, 2H), 5.96–6.05 (m, 1H),
7.24–7.68 (m, 4H), 8.15 (s, 1H), 8.46 (s, 1H). Compound 7b was prepared
similarly.
18. To a mixture of oxime 7a (2 mmol, 0.518 g) and Et3N (0.202 g, 2 mmol) in
dichloromethane (8 ml), 10% aqueous NaOCl solution (3.5 ml) was added
dropwise at ꢁ10 °C. The reaction mixture was allowed to stir for 1 h at room
temperature. The organic phase was separated and the solvent was removed
under reduced pressure. Product 8a was purified by preparative TLC using
EtOAc and hexane (7:3) as eluent. Yield: 0.335 g (65%), mp 167–168 °C. 1H
NMR (300 MHz, CDCl3): d 1.33 (s, 6H), 2.68–2.89 (m, 1H), 3.26–3.35 (m, 1H),
3.73–3.94 (m, 1H), 7.20–7.75 (m, 4H), 8.35 (s, 1H). 13C NMR (75 MHz, CDCl3): d
27.06 (2C), 32.34, 56.28, 69.26, 112.52, 115.18, 119.58, 121.04, 122.89, 128.60,
129.37, 142.66, 157.29. m/z [M+H]+ 259.4. CHN analysis (calcd) C, 65.11; H,
5.42; N, 10.85%; C14H14N2OS (found) C, 64.99; H, 5.32; N, 10.88%. Compound
8b. Yield: 0.337 g (62%), mp 184–185 °C. 1H NMR (300 MHz, CDCl3): d 1.33 (s,
6H), 2.69–2.92 (m, 1H), 3.23–3.37 (m, 1H), 3.63 (s, 3H), 3.72–3.95 (m, 1H),
7.23–7.77 (m, 4H), 8.39 (s, 1H). 13C NMR (75 MHz, CDCl3): d 27.12 (2C), 33.74,
36.78, 55.22, 69.69, 113.69, 115.84, 119.91, 121.58, 122.70, 127.25, 130.48,
143.74, 158.74. m/z [M+H]+ 273.6. CHN analysis (calcd) C, 66.17; H, 5.88; N,
10.29; C15H16N2OS (found) C, 65.98; H, 5.64; N, 10.58.
9. Majumder, S.; Bhuyan, P. J. Synlett 2011, 1547.
10. (a) Baruah, B.; Bhuyan, P. J. Tetrahedron 2009, 65, 7099; (b) Deb, M. L.;
Majumder, S.; Baruah, B.; Bhuyan, P. J. Synthesis 2010, 929; (c) Deb, M. L.;
Bhuyan, P. J. Synlett 2008, 325; (d) Deb, M. L.; Bhuyan, P. J. Synthesis 2008, 2891.
11. Lu, S. C.; Duan, X. Y.; Shi, Z. J.; Li, B.; Ren, Y. W.; Zhang, W.; Zhang, Y. H.; Tu, Z. F.
Org. Lett. 2009, 11, 3902.
12. Majumder, S.; Bhuyan, P. J. Synlett 2011, 2, 173.
13. Ceulemans, E.; Voets, M.; Emmers, S.; Uytterhoeven, K.; Meervelt, L. V.;
Dehaen, W. Tetrahedron 2002, 58, 531.
14.
A solution of 1-bromo-3-methyl-2-butene (2 mmol, 0.298 g), thiourea
(3 mmol, 0.228 g) in ethanol (5 mL) was refluxed for 1 h. After addition of
sodium hydroxide (10 mmol, 0.40 g) in ethanol (5 mL) the reaction was
continued for an additional 1 h and then N-Boc protected 2-chloro-3-indolo
carbaldehyde 3a (2 mmol, 0.558 g) was added. The mixture was refluxed for
half an hour and then water (10 mL) was added. The reaction mixture was
extracted with dichloromethane (3 ꢀ 20 mL). The combined extracts were
dried over anhydrous sodium sulphate, the solvent evaporated and the residue
was purified by column chromatography using petroleum ether–ethylacetate
as eluent (7:3). 4a. Yield: 0.352 g (72%), mp 114–115 °C. 1H NMR (300 MHz,
CDCl3): d 1.35 (s, 3H), 1.70 (s, 3H), 3.45 (d, J = 8.04 Hz, 2H), 5.30–5.34 (m, 1H),
7.2–7.38 (m, 4H), 8.78 (s, br, 1H), 10.18 (s, 1H).
15. Jacquemard, U.; Beneteau, V.; Lefoix, M.; Routier, S.; Merour, J.-Y.; Coudert, G.
Tetrahedron 2004, 60, 10039.
16. To a solution of 2-thioprenyl-3-indolo carbaldehyde 4a (2 mmol, 0.488 g) in
5 ml ethanol was added MeNHOH/HCl (3 mmol, 0.250 g) and the reaction
mixture was set on reflux. NaOH (0.120 g, 3 mmol) was added portion-wise
over a period of 5 min and refluxed for another 2 h. The solvent was removed